Anne-France Moreau counsels clients on corporate and general commercial law, with a particular focus on pharmaceutical, medical device and health care industries. Anne-France has experience on a number of merger, acquisition and private equity transactions, including divestitures, financing rounds and joint ventures for French and non-French corporations. She assists French and non-French groups in the preparation and negotiation of collaborations, licenses and distribution agreements. She also advises companies in the health care sector in connection with pharmaceutical and regulatory issues.

Mehr anzeigen

Ausgewählte Referenzmandate

  • Assisted Innate Pharma in its research collaboration and licensing agreement with Sanofi to apply Innate Pharma’s new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through the activating receptor NKp46
  • Advised Innate Pharma, as part of the McDermott team, in its exclusive licensing agreement with OREGA Biotech that grants Innate Pharma full, worldwide rights to OREGA Biotech’s program of first-in-class anti-CD39 checkpoint inhibitors
  • Advised Pierre Fabre on the Framework of Collaboration Agreement with Array BioPharma to globally develop and commercialize Array’s two late-stage oncology molecules: binimetinib and encorafenib

Mehr anzeigen


  • Legal 500, Recommended Lawyer, 2019


University of Paris I Panthéon-Sorbonne, Licence in Private Law, 2006
University of Paris I Panthéon-Sorbonne, Master’s 1, Business Law, 2007
University of Paris V Descartes, Master’s 2, Business and European Law, 2008


Mehr anzeigen

Anne-France Moreau

Einblicke & Events / Medien

Paris, France / McDermott Event / June 19, 2018